opgn stock forecast zacks

0017 187 CLOSED AT 400 PM ET ON Feb 11 2022. The views and opinions expressed herein are the views and opinions of the author and do not necessarily.

Orbital Energy Group Inc Oeg Stock Price Quote News Stock Analysis

OPGN 087 002 202.

. Common Stock OPGN. Click here - the OPGN analysis is free About Price and. This compares to loss of 061 per share a year ago.

This compares to loss of 049 per share a year ago. View analysts price targets for OpGen or view top-rated stocks among Wall Street analysts. Zacks picks shot up 36 40 even 46 in the past 30 days.

Consolidated Edisons EVEBITDA multiple stands at 1021 close to its high range of 1052 over the last one year and higher than its mid-range of 988. OpGen Inc a precision medicine company engages in developing molecular information products and services in the United States and internationally. Read our earnings report guide before you consider the forecast information when.

Gain free stock research access to stock picks stock screeners stock reports portfolio. Zacks is the leading investment research firm focusing on stock research analysis and recommendations. The company utilizes molecular diagnostics and informatics to help.

The average twelve-month price target for OpGen is 350 with a high price target of 400 and a low price target of 300. OpGen to Provide Business Update and Financial Results for the Second Quarter 2020. OPGN came out with a quarterly loss of 031 per share versus the Zacks Consensus Estimate of a loss of 029.

An industry with a larger percentage of Zacks Rank 1s and 2s will have a better average Zacks Rank than one with a larger percentage of Zacks Rank 4s and 5s. OPGN came out with a quarterly loss of 019 per share in line with the Zacks Consensus Estimate. Common Stock OPGN Nasdaq Listed.

Zacks Investment Research is releasing its prediction for OPGN based on the 1-3 month trading system that nearly triples the SP 500. According to Zacks OpGen Inc. These figures are adjusted for.

Their forecasts range from 300 to 400. OpGen NASDAQ Updated Mar 11 2022 1059 PM. Zacks Investment Research is releasing its prediction for OPGN based on the 1-3 month trading system that nearly triples the SP 500.

The brokerage presently has a 075 price target on the medical research companys stock. This suggests a possible upside of 3228 from the stocks current price. Zacks Investment Researchs price objective points to a potential.

OpGen - Full Company Report. Get the latest Full Company Report for OpGen from Zacks Investment Research. OPGN stock quote history news and other vital information to help you with your stock trading and investing.

The industry with the best average Zacks Rank would be considered the top industry 1 out of 265 which would place it in the top 1 of Zacks Ranked Industries. Ad Nasdaq Morningstar and others use Zacks research but you wont see these picks there. Is a microbial genetics analysis company.

These figures are. Click here - the. Data is currently not available.

On average they anticipate OpGens stock price to reach 350 in the next year. Learn more on OPGNs analyst rating history. Find the latest OpGen Inc.

The 2 analysts offering 12-month price forecasts for OpGen Inc have a median target of 350 with a high estimate of 400 and a. The Company offers optical mapping services for analysis of microbial yeast and fungal genomic architecture. According to the issued ratings of 2 analysts in the last year the consensus rating for OpGen stock is Buy based on the current 2 buy ratings for OPGN.

Opgen Inc Opgn Stock Price Quote News Stock Analysis